Global Amantadine HCl Oral Industry Outlook 2021: Overview, Opportunities, Key Companies and Forecast to 2027
Report Code: KNJ918404 No. of Pages: 146 Category: Pharmaceuticals and Healthcare
Publisher: Date of Publish:
Publisher: Date of Publish:
Executive Summary
According to GRD Survey data, the global Amantadine HCl Oral market was valued at million US$ in 2020 and is expected to million US$ by the end of 2027, growing at a CAGR of % in the forecast period 2021 and 2027.
This report studies the Amantadine HCl Oral market dynamics from angles such as new entries, mergers and acquisitions, fundings, exit and major technology breakthroughs. Market performance is evaluated through market size (value and volume) by players, regions, product types and end industries. This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.
Geographically, this report is segmented into several key regions, with sales, revenue, market share and growth Rate of Amantadine HCl Oral in these regions, from 2016 to 2027, covering
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Italy, Spain and Russia, etc.)
Asia-Pacific (China, Japan, Korea, Southeast Asia, India, Australia)
South America (Brazil, Argentina, Colombia, etc.)
Middle East and Africa (Turkey, Saudi Arabia, South Africa, etc.)
Market Snapshot, By Product Type
Tablet
Capsules
Syrup
Market Snapshot, By Application
Parkinson's Disease
Influenza
Market Snapshot, By Region:
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Spain
Asia Pacific
China
Japan
Korea
Southeast Asia
India
Australia
Central & South America
Brazil
Argentina
Colombia
Middle East & Africa
Iran
South Africa
Israel
Turkey
Saudi Arabia
Main Market Players Analyzed in this report, including:
Zydus Pharmaceuticals
Wockhardt Bio AG
Vertical Pharmaceuticals
Upsher-Smith
Teva
Strides Pharma
Sandoz
Pharmaceutical Associates, Inc. (PAI)
Mylan
Mikart Pharmaceuticals
Heritage Pharmaceuticals
Graviti Pharma
CMP Pharma
Bionpharma
Alembic Pharmaceuticals
Adamas Pharmaceuticals
The study objectives of this report are:
To study and analyze the global Amantadine HCl Oral market size (value & volume) by company, key regions/countries, products and application, history data from 2016 to 2020, and forecast to 2027.
To understand industry structure of Amantadine HCl Oral market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To identify the key global Amantadine HCl Oral manufacturers and regional typical players, to define, describe and analyze their sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Amantadine HCl Oral market with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Amantadine HCl Oral submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
In this study, the years considered to estimate the market size of Amantadine HCl Oral are as follows:
History Year: 2016-2020
Base Year: 2020
Estimated Year: 2021
Forecast Year 2021 to 2027
This report includes the estimation of market size in terms of value (million USD) and volume from top-down approach by analyzing major submarkets and their major driving factors, and verified from bottom-up approaches. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified from primary sources.
For the data information by region, company, type and application, 2020 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Key Stakeholders Considered in the study:
Raw material vendors
Distributors/traders/wholesalers/suppliers
Regulatory authorities, including government agencies and NGO
Commercial research & development (R&D) institutions
Importers and exporters
Government organizations, research organizations, and consulting firms
Trade/Industrial associations
End-use industries
Table of Contents
1 Market Definition & Scope
1.1 Definition & Scope
1.2 Amantadine HCl Oral Product Specifications
1.3 Main Events (Entry, M&A, Exit, Technology and Capital Activity)
1.4 Global Amantadine HCl Oral Market Performance and Outlook
2 Market Development Performance under COVID-19
2.1 Influencing Factors of Industry Development in the Next Five Years
2.1.1 Drivers
2.1.2 Restraints
2.1.3 Opportunities
2.2 Porter’s Five Forces Analysis
2.3 Comparison of Alternatives and Amantadine HCl Oral
3 Supply Chain and Manufacturing Cost Analysis
3.1 Supply Chain Analysis
3.2 Raw Materials and Key Suppliers Analysis
3.2.1 Raw Materials Introduction
3.2.1 Raw Materials Key Suppliers List
3.3 Amantadine HCl Oral Sales Channel and Distributors Analysis
3.3.1 Amantadine HCl Oral Sales Channel
3.3.2 Amantadine HCl Oral Distributors
3.4 Key Buying Industries/Consumers
3.4.1 Major Buyers in Parkinson's Disease
3.4.2 Major Buyers in Influenza
3.5 Amantadine HCl Oral Manufacturing Cost Structure Analysis
4 Market Segment: by Type
4.1 Amantadine HCl Oral Type Introduction
4.1.1 Tablet
4.1.2 Capsules
4.1.3 Syrup
4.2 Global Amantadine HCl Oral Sales by Type 2016-2021
4.3 Global Amantadine HCl Oral Revenue by Type 2016-2021
4.4 Global Amantadine HCl Oral Price by Type 2016-2021
5 Market Segment: by Application
5.1 Amantadine HCl Oral Type Introduction
5.1.1 Parkinson's Disease
5.1.2 Influenza
5.2 Global Amantadine HCl Oral Sales by Application 2016-2021
5.3 Global Amantadine HCl Oral Revenue by Application 2016-2021
5.4 Global Amantadine HCl Oral Price by Application 2016-2021
6 Marke Segment: by Region
6.1 Global Amantadine HCl Oral Market by Region
6.1.1 Global Amantadine HCl Oral Sales by Regions
6.1.2 Global Amantadine HCl Oral Revenue by Regions
6.2 North America Amantadine HCl Oral Market 2016-2021
6.3 Europe Amantadine HCl Oral Market 2016-2021
6.4 Asia Pacific Amantadine HCl Oral Market 2016-2021
6.5 South America Amantadine HCl Oral Market 2016-2021
6.6 Middle East and Africa Amantadine HCl Oral Market 2016-2021
7 North America
7.1 North America Amantadine HCl Oral Market by Country 2016-2021
7.1.1 North America Amantadine HCl Oral Sales by Country
7.1.2 North America Amantadine HCl Oral Revenue by Country
7.2 United States
7.3 Canada
7.4 Mexico
8 Europe
8.1 Europe Amantadine HCl Oral Market by Country 2016-2021
8.1.1 Europe Amantadine HCl Oral Sales by Country
8.1.2 Europe Amantadine HCl Oral Revenue by Country
8.2 Germany
8.3 France
8.4 UK
8.5 Italy
8.6 Russia
8.7 Spain
9 Asia Pacific
9.1 Asia Pacific Amantadine HCl Oral Market by Country 2016-2021
9.1.1 Asia Pacific Amantadine HCl Oral Sales by Country
9.1.2 Asia Pacific Amantadine HCl Oral Revenue by Country
9.2 China
9.3 Japan
9.4 Korea
9.5 Southeast Asia
9.6 India
9.7 Australia
10 South America
10.1 South America Amantadine HCl Oral Market by Country 2016-2021
10.1.1 South America Amantadine HCl Oral Sales by Country
10.1.2 South America Amantadine HCl Oral Revenue by Country
10.2 Brazil
10.3 Argentina
10.4 Colombia
11 Middle East and Africa
11.1 Middle East and Africa Amantadine HCl Oral Market by Country 2016-2021
11.1.1 Middle East and Africa Amantadine HCl Oral Sales by Country
11.1.2 Middle East and Africa Amantadine HCl Oral Revenue by Country
11.2 Turkey
11.3 Saudi Arabia
11.4 South Africa
12 Key Participants Company Information
12.1 Zydus Pharmaceuticals
12.1.1 Zydus Pharmaceuticals
Company Information
12.1.2 Zydus Pharmaceuticals
Amantadine HCl Oral Product Portfolio, Specification and Application
12.1.3 Zydus Pharmaceuticals
Amantadine HCl Oral Sales, Price, Revenue and Gross Margin (2019-2021)
12.1.4 Zydus Pharmaceuticals
Key Development
12.2 Wockhardt Bio AG
12.2.1 Wockhardt Bio AG
Company Information
12.2.2 Wockhardt Bio AG
Amantadine HCl Oral Product Portfolio, Specification and Application
12.2.3 Wockhardt Bio AG
Amantadine HCl Oral Sales, Price, Revenue and Gross Margin (2019-2021)
12.2.4 Wockhardt Bio AG
Key Development
12.3 Vertical Pharmaceuticals
12.3.1 Vertical Pharmaceuticals
Company Information
12.3.2 Vertical Pharmaceuticals
Amantadine HCl Oral Product Portfolio, Specification and Application
12.3.3 Vertical Pharmaceuticals
Amantadine HCl Oral Sales, Price, Revenue and Gross Margin (2019-2021)
12.3.4 Vertical Pharmaceuticals
Key Development
12.4 Upsher-Smith
12.4.1 Upsher-Smith
Company Information
12.4.2 Upsher-Smith
Amantadine HCl Oral Product Portfolio, Specification and Application
12.4.3 Upsher-Smith
Amantadine HCl Oral Sales, Price, Revenue and Gross Margin (2019-2021)
12.4.4 Upsher-Smith
Key Development
12.5 Teva
12.5.1 Teva
Company Information
12.5.2 Teva
Amantadine HCl Oral Product Portfolio, Specification and Application
12.5.3 Teva
Amantadine HCl Oral Sales, Price, Revenue and Gross Margin (2019-2021)
12.5.4 Teva
Key Development
12.6 Strides Pharma
12.6.1 Strides Pharma
Company Information
12.6.2 Strides Pharma
Amantadine HCl Oral Product Portfolio, Specification and Application
12.6.3 Strides Pharma
Amantadine HCl Oral Sales, Price, Revenue and Gross Margin (2019-2021)
12.6.4 Strides Pharma
Key Development
12.7 Sandoz
12.7.1 Sandoz
Company Information
12.7.2 Sandoz
Amantadine HCl Oral Product Portfolio, Specification and Application
12.7.3 Sandoz
Amantadine HCl Oral Sales, Price, Revenue and Gross Margin (2019-2021)
12.7.4 Strides Pharma
Key Development
12.9 Mylan
12.9.1 Mylan
Company Information
12.9.2 Mylan
Amantadine HCl Oral Product Portfolio, Specification and Application
12.9.3 Mylan
Amantadine HCl Oral Sales, Price, Revenue and Gross Margin (2019-2021)
12.9.4 Mylan
Key Development
12.8 Pharmaceutical Associates, Inc. (PAI)
12.8.1 Pharmaceutical Associates, Inc. (PAI)
Company Information
12.8.2 Pharmaceutical Associates, Inc. (PAI)
Amantadine HCl Oral Product Portfolio, Specification and Application
12.8.3 Pharmaceutical Associates, Inc. (PAI)
Amantadine HCl Oral Sales, Price, Revenue and Gross Margin (2019-2021)
12.8.4 Pharmaceutical Associates, Inc. (PAI)
Key Development
12.11 Heritage Pharmaceuticals
12.11.1 Heritage Pharmaceuticals
Company Information
12.11.2 Heritage Pharmaceuticals
Amantadine HCl Oral Product Portfolio, Specification and Application
12.11.3 Heritage Pharmaceuticals
Amantadine HCl Oral Sales, Price, Revenue and Gross Margin (2019-2021)
12.11.4 Heritage Pharmaceuticals
Key Development
12.12 Graviti Pharma
12.12.1 Graviti Pharma
Company Information
12.12.2 Graviti Pharma
Amantadine HCl Oral Product Portfolio, Specification and Application
12.12.3 Graviti Pharma
Amantadine HCl Oral Sales, Price, Revenue and Gross Margin (2019-2021)
12.12.4 Graviti Pharma
Key Development
12.13 CMP Pharma
12.13.1 CMP Pharma
Company Information
12.13.2 CMP Pharma
Amantadine HCl Oral Product Portfolio, Specification and Application
12.13.3 CMP Pharma
Amantadine HCl Oral Sales, Price, Revenue and Gross Margin (2019-2021)
12.13.4 CMP Pharma
Key Development
12.14 Bionpharma
12.14.1 Bionpharma
Company Information
12.14.2 Bionpharma
Amantadine HCl Oral Product Portfolio, Specification and Application
12.14.3 Bionpharma
Amantadine HCl Oral Sales, Price, Revenue and Gross Margin (2019-2021)
12.14.4 Bionpharma
Key Development
12.15 Alembic Pharmaceuticals
12.15.1 Alembic Pharmaceuticals
Company Information
12.15.2 Alembic Pharmaceuticals
Amantadine HCl Oral Product Portfolio, Specification and Application
12.15.3 Alembic Pharmaceuticals
Amantadine HCl Oral Sales, Price, Revenue and Gross Margin (2019-2021)
12.15.4 Alembic Pharmaceuticals
Key Development
13 Global Amantadine HCl Oral Market Forecast by Region by Type and by Application
13.1 Global Amantadine HCl Oral Sales, Revenue Forecast 2022-2027
13.2 Global Amantadine HCl Oral Forecast by Regions
13.2.1 Global Amantadine HCl Oral Sales Forecast by Region 2022-2027
13.2.2 Global Amantadine HCl Oral Revenue Forecast by Region 2022-2027
13.3 Global Amantadine HCl Oral Forecast by Type
13.3.1 Global Amantadine HCl Oral Sales Forecast by Type 2022-2027
13.3.2 Global Amantadine HCl Oral Revenue Forecast by Type 2022-2027
13.3.3 Global Amantadine HCl Oral Price Forecast by Type 2022-2027
13.4 Global Amantadine HCl Oral Forecast by Application
13.4.1 Global Amantadine HCl Oral Sales Forecast by Application 2022-2027
13.4.2 Global Amantadine HCl Oral Revenue Forecast by Application 2022-2027
13.4.3 Global Amantadine HCl Oral Price Forecast by Application 2022-2027
14 Analyst Views and Conclusions
15 Methodology and Data Source
15.1 Methodology
15.2 Research Data Source
15.2.1 Secondary Data
15.2.2 Primary Data
15.2.3 Market Size Estimation
15.3 Legal Disclaimer
NEED Help?
If you need any help or guidance, please feel free to call us.
USA : +1 (661) 636 6162
INDIA : +91 9325802062
or
Write us on : sales@kandjmarketresearch.com